Browsing Tag
Clinuvel Pharmaceuticals
2 posts
Clinuvel Pharmaceuticals (ASX: CUV) share price gains after EMA approves year-round SCENESSE dosing
Clinuvel Pharmaceuticals (ASX: CUV) gains EMA approval for year-round SCENESSE dosing, boosting patient access, revenues, and investor sentiment.
Can SCENESSE become the first approved EPP treatment in Canada? Clinuvel files with Health Canada
Clinuvel Pharmaceuticals files for SCENESSE approval in Canada, aiming to bring the first-ever EPP treatment to patients. Find out how it could change lives.